company background image
HTL

Hamilton Thorne TSXV:HTL Stock Report

Last Price

CA$1.60

Market Cap

CA$231.1m

7D

1.3%

1Y

-14.0%

Updated

27 Sep, 2022

Data

Company Financials +
HTL fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance0/6
Financial Health6/6
Dividends0/6

HTL Stock Overview

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets.

Hamilton Thorne Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hamilton Thorne
Historical stock prices
Current Share PriceCA$1.60
52 Week HighCA$2.20
52 Week LowCA$1.31
Beta0.90
1 Month Change1.27%
3 Month Change4.58%
1 Year Change-13.98%
3 Year Change50.94%
5 Year Change116.22%
Change since IPO321.05%

Recent News & Updates

Shareholder Returns

HTLCA Medical EquipmentCA Market
7D1.3%-6.4%-5.5%
1Y-14.0%-46.7%-7.3%

Return vs Industry: HTL exceeded the Canadian Medical Equipment industry which returned -46.8% over the past year.

Return vs Market: HTL underperformed the Canadian Market which returned -8.4% over the past year.

Price Volatility

Is HTL's price volatile compared to industry and market?
HTL volatility
HTL Average Weekly Movement4.6%
Medical Equipment Industry Average Movement10.1%
Market Average Movement9.8%
10% most volatile stocks in CA Market18.1%
10% least volatile stocks in CA Market3.8%

Stable Share Price: HTL is less volatile than 75% of Canadian stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: HTL's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/an/aDavid Wolfhttps://www.hamiltonthorne.ltd

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets under the Hamilton Thorne brand; test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services under the Embryotech brand. The company also manufactures and distributes products for reproductive medicine, including clinical and laboratory equipment and disposables, as well as complete installations of ART clinics under the Gynemed brand; and bench top incubators, programmable freezers, loggers, alarms, cryo storage, and software systems and sensors for the safe preservation of medical and biological specimens used in ART and cell biology applications under the Planer brand.

Hamilton Thorne Ltd. Fundamentals Summary

How do Hamilton Thorne's earnings and revenue compare to its market cap?
HTL fundamental statistics
Market CapCA$231.06m
Earnings (TTM)CA$2.64m
Revenue (TTM)CA$77.82m

87.7x

P/E Ratio

3.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
HTL income statement (TTM)
RevenueUS$56.59m
Cost of RevenueUS$28.72m
Gross ProfitUS$27.87m
Other ExpensesUS$25.96m
EarningsUS$1.92m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.013
Gross Margin49.25%
Net Profit Margin3.39%
Debt/Equity Ratio9.5%

How did HTL perform over the long term?

See historical performance and comparison